Clinical significance of keap1 and Nrf2 in oral squamous cell carcinoma

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Huang, Cong Fa ^a   Zhang, Lu ^a   Ma, Si Rui ^a   Zhao, Zhi Li ^a   Wang, Wei Ming ^a   He, Ke Fei ^a   Zhao, Yi Fang ^a   Zhang, Wen Feng ^a   Liu, Bing ^a   Sun, Zhi Jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS, CD147; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; CYCLOPHILIN A; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; NF-E2-RELATED FACTOR 2; PATIENT OUTCOME ASSESSMENT; PEROXIREDOXIN VI; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893559180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083479     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
2. Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, et al. (2012) Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 9: 329-335.
3. Chen Y, Azad MB, Gibson SB (2009) Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 16: 1040-1052.
4. Wu WS (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25: 695-705.
5. Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, et al. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35: 238-245. (Pubitemid 37363177)
6. Hartikainen JM, Tengstrom M, Kosma VM, Kinnula VL, Mannermaa A, et al. (2012) Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer. Cancer Res 72: 5537-5546.
7. Shanmugam MK, Nguyen AH, Kumar AP, Tan BK, Sethi G (2012) Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer. Cancer Lett 320: 158-170.
8. Ronkainen H, Vaarala MH, Kauppila S, Soini Y, Paavonen TK, et al. (2009) Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma. Oncol Rep 21: 1519-1523.
9. Huang C, Sun Z, Sun Y, Chen X, Zhu X, et al. (2012) Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 60: 793-803.
10. Zhu X, Huang C, Peng B (2011) Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol 47: 609-614.
11. Huang CF, Sun ZJ, Zhao YF, Chen XM, Jia J, et al. (2011) Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue. Oral Dis 17: 328-334.
12. Dai L, Guinea MC, Slomiany MG, Bratoeva M, Grass GD, et al. (2013) CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells. Am J Pathol 182: 577-585.
13. Li M, Zhai Q, Bharadwaj U, Wang H, Li F, et al. (2006) Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106: 2284-2294. (Pubitemid 43673252)
14. Sun ZJ, Zhang L, Hall B, Bian Y, Gutkind JS, et al. (2012) Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin Cancer Res 18: 5304-5313.
15. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868. (Pubitemid 29003722)
16. Saldanha AJ (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
17. Stacy DR, Ely K, Massion PP, Yarbrough WG, Hallahan DE, et al. (2006) Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 28: 813-818. (Pubitemid 44320535)
18. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, et al. (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109.
19. Paschos A, Pandya R, Duivenvoorden WC, Pinthus JH (2013) Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics. Prostate Cancer Prostatic Dis 16: 217-225.
20. Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34: 340-346.
21. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, et al. (2008) Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135: 1358-1368, 1368 e1351-1354.
22. Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, et al. (2011) Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer 10: 37.
23. Chang LC, Fan CW, Tseng WK, Chen JR, Chein HP, et al. (2013) Immunohistochemical Study of the Nrf2 Pathway in Colorectal Cancer: Nrf2 Expression is Closely Correlated to Keap1 in the Tumor and Bach1 in the Normal Tissue. Appl Immunohistochem Mol Morphol.
24. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, et al. (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303-1309. (Pubitemid 351346836)
25. Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, et al. (2007) Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-554. (Pubitemid 46192191)
26. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, et al. (2010) Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 16: 3743-3753.
27. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, et al. (2012) Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 103: 760-766.